keren for website

Education:

2006-2009 B.Sc.
George S. Wise Faculty of Life Sciences, Tel Aviv University

2010-2015 Ph.D.
George S. Wise Faculty of Life Sciences, Tel Aviv University
Thesis:
Supervisor: Prof. Dan Peer

Position & Employment:

2008-2009: Teaching assistant in "Cell biology" course

2011-2012: Teaching assistant in "Cell biology" course

Publications:

1. Rivkin I, Cohen K, Koffler J, Malichov D, Peer D* and Margalit R* (2010). Paclitaxel-clusters coated with hyaluronan as selective tumor-targeting nanovectors. Biomaterials 31:7106-7114. * denoted equal contribution. PDF

2. Bachar G*, Cohen K*, Hod R, Feinmesser R, Mizrachi A, Shpitzer T, Katz O, Peer D. (2011). Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers. Biomaterials. 32: 4840-4848. *denoted equal contribution.PDF

3. Mizrahy S, Raz SR, Hasgaard M, Liu H, Soffer-Tsur N, Cohen K, Dvash R, Landsman-Milo D, Bremer MG, Moghimi SM, Peer D. (2011). Hyaluronan-coated nanoparticles: The influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J. of Cont. Release. 156(2):231-238. PDF

4. Breiner-Goldstein E, Evron Z, Frenkel M, Cohen K, Nir Meiron K, Peer D, Roichman Y,Flescher E, and Fridman M (2011). Targeting Anthracycline-resistant Tumor Cells with Synthetic Aloe-emodin Glycosides. ACS Medicinal chemistry letters 2: 528-531.

5. Cohen K, Emmanuel R., Kisin-Finfer E., Shabat D., and Peer, D. (2014). Modulation of Drug Resistance in Ovarian Adenocarcinoma using Chemotherapy Entrapped in Hyaluronan-Grafted Nanoparticle Clusters. ACS Nano. 8(3), 2183-2195. PDF

6. Jacoby G., Cohen K., Tamon I., Peer D *. and Back-Barkai R* (2015). Metastability in lipid based particles exhibits temporally deterministic and controllable behavior. Scientific Reports, *denotes equal contribution. Scientific Reports, 5:9481.*denotes equal contribution. PDF

7. Ganoth A, Cohen K.M, and Peer D (2015). Overcoming multidrug resistance with drug delivery strategies. Expert Opinion on Drug Delivery, 12(2), 223-338. PDF